A legacy that inspires the Future.
For over half a century, Cordis has connected and collaborated across the industry, with a mission to invent better ways to serve clinicians and their collaborators. As a global leader in breakthrough cardiovascular and endovascular solutions, we are the people behind the people who keep saving lives.
Innovating and Delivering New Technologies
Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB). Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with the SELUTION SLR™ DEB. Cordis and MedAlliance combined are committed to accelerating the development and commercialization of innovative cardiovascular interventional products around the world.
The SELUTION SLRTM Drug-Eluting Balloon is not approved for sale in every country. Please contact your local representative for additional information
RAIN Sheath™ Transradial Thin-walled Introducer
The RAIN Sheath™ Transradial Thin-walled Introducer brings innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity.
MYNX CONTROL™ Vascular Closure Device
Closes with security. Leave nothing behind*. MYNX CONTROL™ Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety and ease of use.
* The sealant is resorbed by the body within 30 days
Driven by mission, guided by values
Cordis is making a difference. We impact millions of lives, in more than 60 countries around the world. We embrace a diverse, empowered culture where teammates are inspired to serve customers, patients and shareholders while fulfilling their own career aspirations.
Need Help?
We’re here with the support and information to help you make the right choices for your patients.